Efficacy of early transfusion of convalescent plasma with high-titer SARS-CoV-2 neutralizing antibodies in hospitalized patients with COVID-19 - DocWire News

3/26/2022 12:00:00 AM3 years 1 month ago

Transfusion. 2022 Mar 26. doi: 10.1111/trf.16863. Online ahead of print.ABSTRACTBACKGROUND: Despite most controlled trials have shown no measurable

Transfusion. 2022 Mar 26. doi: 10.1111/trf.16863. Online ahead of print. ABSTRACT BACKGROUND: Despite most controlled trials have shown no measurable benefit of COVID-19 convalescent plasma (CCP) i… [+1678 chars]

full article...